08:45-09:00

                   Opening Ceremoney

Jia-Kuo Yu

Title- Study on feasibility of the partial meniscal allograft transplantation

Speaker Abstract

Since the meniscus is an important stabilizing structure of the knee joint and has a significant role in load-bearing and shock absorption, so the complete structural and functional reconstructions of the teared menisci should be done not only after partial meniscectomy but also post total meniscectomy. So far, animal experiments and good clinical practice have showed that the total meniscus allograft transplantation (TMAT) after total meniscectomy has partially solved the problem of structural and functional reconstructions after total meniscectomy. However, partial meniscectomy will also lead to accelerated knee degeneration, and its proportion is much higher than that of patients with total meniscectomy.Herein, the feasibility of partial meniscus allograft transplantations (PMAT) after partial meniscectomy was investigated for the first time by using the 40% posterior horn meniscectomy model of the medial meniscus in Beagle dogs, and also for the first time, TMAT group and the total meniscectomy group were used as control groups. Compared with the TMAT, the transcriptomics evaluation, scanning electron microscope observation, histological regeneration and structure, biomechanical property, inflammation environment, and the knee function post PMAT were more similar to that of normal meniscus was first reported. This study provides a PMAT scheme with clinical translational value for the complete structural and functional reconstruction of the patients with partial meniscectomy and fills the gap in the field of teared meniscus therapy on the basis of quite well clinical applications of the meniscus repair and the TMAT

Speaker Biography

Jia-Kuo Yu, PhD supervisor, director of the Institute of Sports Medicine of Peking University, director of the Department of Sports Medicine and Knee Surgery of Peking University Third Hospital. Studied in Germany as a senior visiting scholar between 1999 and 2001. Expert enjoying the special allowance of The State Council. Chairman of Geriatric Sports Medicine Branch of Chinese Society of Gerontology and Geriatrics.Group leader of Passive Implants of Medical Device Classification Technical Committee of State Drug Administration. Vice chairman of biomaterial advanced manufacturing branch of Chinese biomaterials Society. 99 English articles were published as the first author or corresponding author. 10 monographs of the chief editor or deputy chief editor. 66 patents have been granted (including 18 invention patents), 32 patents have been converted. The total amount of conversion exceeds RMB 100 million.

Listen to this article

Junlan Chuan

Title- The efficacy and safety of brolucizumab for the treatment of nAMD: A systematic review and meta‑analysis

Speaker Abstract

Introduction: Brolucizumab can be used to treat neovascular age-related macular degeneration (nAMD) because it antagonizes vascular endothelial growth factor (VEGF) in the vitreous, as demonstrated in pivotal clinical trials. However, brolucizumab may cause retinal vasculitisobliterans in the presence of inflammation in the eyes. In the present study, a meta-analysis of randomized controlled trials (RCTs) was conducted to evaluate the efficacy and safety of brolucizumab. Methods: Clinic Trail.gov., Embase, Cochrane library, Pubmed were retrieved from inception until December 31th, 2021 for RCTs assessing the efficacy and safety of brolucizumab. Changes in Best Corrected Visual Acuity (BCVA), and Central Sub-Field Thickness (CSFT), incidence of adverse events, serious adverse events and serious ocular adverse events were extracted from eligible RCTs. Meta-analysis was performed using Revman 5.4.1. Results: Six RCTs with 3574 participants were finally involved in this meta-analysis. The changes of BCVA were not statistically significant different between brolucizumab treated group and aflibercept group. Brolucizumab induced higher CSFT reduction compared with control agent (aflibercept). The incidence of adverse events was similar between brolucizumab group and control group (OR 0.63, 95% CI 0.37 to 1.08, P=0.09), and brolucizumab caused less serious adverse events (OR 0.78, 95% CI 0.63 to 0.95, P=0.01). However, brolucizumab could lead to more serious ocular adverse events than lucentis and aflibercept (OR 2.15, 95% CI 1.11 to 4.16, P=0.02). Conclusion:Brolucizumab was non-inferior to other anti-VEGF agents in improving BCVA and decrease CSFT. But it caused more serious ocular adverse events which is worthy of special attention by ophthalmologists.

Speaker Biography

Listen to this article

X Wu

Title- Retroviral vectorization for ex vivo gene therapy

Speaker Abstract

Vectorization of viruses provides the approach to exploit the remarkable viral capabilities of delivering genetic material to host cells. In the past decade, viral vector mediated gene therapy has emerged as a promising therapeutic modality for multiple inherited and acquired human diseases. Following just a single application, GT is capable of providing curative treatment or achieving long-lasting therapeutic benefits, which fundamentally distinguishes itself from traditional medicine. For the last four decades, retrovirus-based genetic intervention has been the major player in the field of GT, and multiple lentiviral/γ-retroviral vector-mediated GT products have been approved for treating various pathological conditions, including immunodeficiency, blood disorders and neurometabolic disorders. However, the early development of GT had been turbulent, with unexpected devastating effects exposed linked to the genotoxicities associated with retroviral semi-random genomic insertion. Here we talk about how the iterative vectorization processes taming the retroviruses, enabling them to become the foundation of modern gene therapy. And we will also take an evolutionary perspective to understand and perceive how retroviruses shaped us in the distant past.

Speaker Biography

Dr. Xiaomo Wu is the head of Regenerative Medicine LAB and the deputy Director of theDermatology Institute of Fuzhou, China. Wu received a B.A. in Medicine in 2002 from theUniversity of Wuhan, followed by M.S. in Genetics in 2006 from the University of Fudan, Shanghai. In 2008, Wu came to Biozentrum, the University of Basel, Switzerland andreceivedPhD in Genetics in 2012 under Walter J. Gehring. She conducted her postdoctoral research in Bettler’s LAB, Department of Biomedicine (DBM), also from the University of Basel, Switzerland. In 2017, Wu was recruited as a lad head and the deputy director of a newly founded institute in the Dermatology Hospital of Fuzhou, Fujian, China. In recent years, WU Lab has been dedicated to developing therapeutic interventions based on genetic modification and alteration, namely gene therapy, for treating multiple inherited skin diseases as well as some types of blood disorders.

Listen to this article

Tao Qiu

Title- Subclavian artery stenting via bilateral radial artery approach

Speaker Abstract

Background: Subclavian artery stenosis refers to the stenosis in the lumen caused by the presence of plaque or thrombus in the subclavian artery. It is a common problem in endovascular interventions. In fact, conventional subclavian artery stenting via the femoral artery approach is effective and safe. Nevertheless, because femoral artery puncture is not easy to stop bleeding, it requires longer femoral artery compression or more expensive hemostatic materials, such as staplers. Patients need to be catheterized and bedridden for a longer time, which may lead to many complications, such as pseudoaneurysm. Method Summary: We report a new subclavian artery interventional therapy. Through the bilateral radial artery approach, the 5F radial artery sheath was inserted on the opposite side of the lesion, and the 5F SM2 contrast tube was used for imaging positioning. The 6F radial artery sheath was inserted on the side of the lesion, and the guide wire was used to directly guide the stent to the subclavian stenosis without using the guide tube. Conclusion: Reviewing the successful placement of clavicular artery stents through bilateral radial arteries in our center, we believe that bilateral radial artery approach is feasible. Clavicular artery stenting is safe, effective and time-saving. It is an excellent alternative to traditional femoral artery surgery, with few complications and high comfort.

Speaker Biography

Qiu Tao, deputy chief physician, MD, master's supervisor, director of Neurology Department of Zigong first people's hospital. He studied in Italy in 2017. Member of the transradial interventional cooperative group of the Neurointerventional branch of the Chinese Research Hospital Association; Vice chairman of the Special Committee on nerve intervention of Sichuan society of traditional Chinese medicine; Vice chairman of stroke prevention and Treatment Society of Sichuan medical communication society. Reviewer of frontiers in bioscience landmark and Journal of clinical neurology. He is mainly engaged in the clinical and research work of ischemic cerebrovascular disease and nerve intervention. In 2009, he took the lead in conducting cerebrovascular intervention diagnosis and treatment in Zigong. It won two second prizes of new technology of Zigong health system. It has made 5 scientific and technological progress in Zigong. He has published 8 SCI papers, edited 2 monographs and won 2 national patents.

Listen to this article

Zehui Y

Title- Prediction and analysis of covid-19 daily new cases and cumulative cases: Time series forecasting and machine learning models

Speaker Abstract

Background: COVID-19 poses a severe threat to global human health, especially the USA, Brazil, and India cases continue to increase dynamically, which has a far-reaching impact on people's health, social activities, and the local economic situation. Methods: The study proposed the ARIMA, SARIMA and Prophet models to predict daily new cases and cumulative confirmed cases in the USA, Brazil and India over the next 30 days based on the COVID-19 new confirmed cases and cumulative confirmed cases data set(May 1, 2020, and November 30, 2021) published by the official WHO, Three models were implemented in the R 4.1.1 software with forecast and prophet package. The performance of different models was evaluated by using root mean square error (RMSE), mean absolute error (MAE) and mean absolute percentage error (MAPE). Results: Through the fitting and prediction of daily new case data, we reveal that the Prophet model has more advantages in the prediction of the COVID-19 of the USA, which could compose data components and capture periodic characteristics when the data changes significantly, while SARIMA is more likely to appear over-fitting in the USA. And the SARIMA model captured a seven-day period hidden in daily COVID-19 new cases from 3 countries. While in the prediction of new cumulative cases, the ARIMA model has a better ability to fit and predict the data with a positive growth trend in different countries(Brazil and India).

Speaker Biography

Listen to this article

M Nishi

Title- Cure interrupted: Life and values during the HIV epidemic in Ethiopia

Speaker Abstract

This presentation examines how the pharmaceutical-driven model of public health has altered forms of HIV care in Ethiopia during the past decade. First, it examines how the efforts to “cure” the lives of some people affected by HIV have been marginalized through the process that some medical anthropologists referred to as the exercise of “triage.” Second, it considers how the process was facilitated by narrowly defined concepts of life and value in mainstream global health discussions by comparing them with the anthropological theory of values. In my ethnographic research in a provincial town in Ethiopia, I examined how the expansion of the antiretroviral treatment program interplayed with local actions through which suffering inflicted by the epidemic was cared for.1 Local health institutions served the town’s population by disseminating antiretrovirals free of charge. However, they referred patients whose problems were too complicated to be solved by the drugs to a local association of people with HIV. I regarded this as an exercise in “triage” because the association was systematically deprived of the resources required to address its members’ needs. Pharmaceutical agents are valuable because of their power to improve life. However, what it means to “make life better” needs clarification. Medical anthropological theory assumes that for all living entities, value arises from life, meaning the value is always embodied.2 The embodied value enhances life to become more relevant to its social and biological environments. However, healthcare theories and practices that do not entertain embodied values fall short of “curing” the lives of persons.

Speaker Biography

Makoto Nishi is an associate professor at the Graduate School of Humanities and Social Sciences,Hiroshima University. His current research projects focus on biosocial etiologies of some neurologicalconditions, including parasite-induced epilepsy in post-conflict northern Uganda and autism during theCOVID-19 pandemic in Japan

Listen to this article

Dhiraj Pandey

Title- Smart health care technologies to support computer aided diagnostics

Speaker Abstract

Cardiovascular diseases (CVD): Now a day’s number one cause of death. The mortality rate due to CVD is around 272 person per lakh in comparison to 235 per person globally.ECG is commonly used signal to detect it for initial findings. Several approaches based on wavelet-based variants on ECG are studied to detect coronary artery diseases and helping the computer aided diagnostic system. Apart from ECG, EEG test is very much popular to detect any brain activity disorder. EEG signals are also used in Brain-computer interfaces (BCIs). Detecting early any diseases or any brain disorder may help us to save lives of several people who commits suicide (eg. Farmers). In this talk, major discussion will be based on how Deep learning-based approaches can be used to improve the diagnosis task. The task primarily consists of two sub problems. First part of the discussion will be focused on identification of abnormal cases, i.e., whether the brain contains any symptoms or not. In the second part classification of the type will be discussed in details. Automatically categorizing the diseases type is a relatively more challenging task comparing to the binary classification of normal and abnormal personal and convolutional neural networks are found to be very successful in biological tasks.

Speaker Biography

Dr. Dhiraj Pandey received his Ph.D. in Computer Science and Engineering from Manipal University in August 2018. He received his B.Tech degree in Information Technology in the year 2003 and an M.Tech degree from the University School of Information Technology, GGSIPU, New Delhi in the year 2007. He has more than 19 years of rich academic experience. He joined the Department of Computer Science and Engineering at JSS Academy of Technical Education Noida in January 2011 and currently working as Associate Professor there. His recent research interests include assistive technologies, image processing, and information security allied areas. He is a Senior Member of IEEE. He has published more than 40 papers in SCI/Scopus indexed Journals and Conferences.

Listen to this article

Niraj Kumar

Title- To evaluate the effect of change in end tidal carbon dioxide on optic nerve sheath diameter under general anaesthesia: A prospective study

Speaker Abstract

Objectives:Primary objective: To evaluate the change in optic nerve sheath diameter (ONSD) with change in end tidal carbon dioxide (EtCO2). Secondary objective: To evaluate if the change in ONSD in response to change in end tidal carbon dioxide is immediate (real time). To evaluate if the change in ONSD is reversible with restoration of end tidal carbon dioxide to previous level. Scope:Elevated intracranial pressure (ICP) is a common and potentially life-threatening condition. The trans-orbital ultrasonography, is a non-invasive method which detects raised ICP by evaluating increases in the optic nerve sheath diameter (ONSD). Dynamic responsiveness of ONSD, in association with acute change in EtCO2, (both hypercapnia and hypocapnia) which can affect ICP, still has not been well investigated. We hypothesized that there would be dynamic changes in ONSD in response to corresponding changes in EtCO2. Results:A strong correlation was found between the corresponding EtCO2 and ONSD values with Pearson’s correlation coefficient of 0.89(fig -1).There was no statistical difference between ONSD values at 0 and 5 minutes after attaining the desired EtCO2 level. The change in ONSD were reversible with EtCO2 reversibility. METHODS: 56 patients, with age between 18-60 years, either sex, and admitted to undergo elective spine surgery under general anaesthesia were included. All patients were exposed to both hypercapnia and hypocapnia and the ONSD values were recorded. However, for the purpose of the study, after induction of GA the respiratory rate was adjusted to attain the desired EtCO2 value (normocapnia, hypocapnia or hypercapnia). ONSD values were obtained at normo-, hyper- and hypo-capnia in all the patients. CONCLUSION:ONSD has a strong correlation with EtCO2 and it changes directly and significantly in response to changes in EtCO2.

Speaker Biography

Niraj Kumar is a professor in the Department of Neuroanesthesiology and critical care, at Aiims, New Delhi. He is actively involved in conducting Research projects (e.g., Intramural, extramural, DM thesis). He has developed novel pressure measuring device for the ultrasound probe with AIIMS –IIT Delhi collaborative project (as Principal investigator), the device is under the patent process. He has completed a fellowship Program: (Clinical Research Methodology and Evidence-Based Medicine) at AIIMS, New Delhi. He is the instructor (Faculty) of –ATLS, ANC, ACCC, AIIMS – EM-SONO, AUTLS, AIIMS cadaver airway. He is the Course Director of - Cadaveric Airway Management Course. He has delivered a series of talks in ultrasound as Course Director - Ultrasound POCUS SERIES - Classroom “an online ISNACC initiative. He has given a series of lectures in the National Live Webinar Series -Neuroanesthesia, conducted by NBEMS (National board of examinations in Medical Sciences).

Listen to this article

Mariam Elsherif

Title- MECOM gene overexpression in pediatric patients with acute myeloid leukemia

Speaker Abstract

Background: Acute myeloid leukemia (AML) is characterized by blocked or aberrant differentiation of hematopoietic stem cells. The MECOM gene overexpression in hematopoietic progenitors induces myeloid differentiation block, resulting in increased self-renewal and survival of these transformed progenitors. However, its exact role in AML remains unclear. We aimed to estimate the prevalence of MECOM over expression among pediatric AML patients, and assess its impact on clinical outcome. Patients and Methods:Real-time quantitative polymerase chain reaction and Livak method (2ΔΔCt) were used to determine relative MECOM expression level among 243 pediatric patients with AML. MECOM overexpression was considered if the cumulative relative expression was above 1 (2-ΔΔCt)and was designatedas MECOMpos. Results: Of 243 AMLpatients tested 57(23.5%) demonstrated MECOMpos. Patients with MECOMpos had significantly lower median age. The frequency of MECOMpos was significantly higher among AML patients with 11q23 abnormalities, complex karyotypes and among high- and intermediate-risk groups compared to low-risk group (P=0.014). MECOMpos patients had significantly lower overall survival (OS) (38.7 vs. 78.9%, P<0.001), event-free survival (EFS) (37.3% vs. 68.4%, P<0.001), and had higher cumulative incidence of relapse (49.5% vs. 23.5%, P=0.002) at 36 months compared to MECOMnegpatients. Multivariate analysis revealed that MECOMpos was an adverse prognostic factor for OS (hazards ratio (HR) = 2.11, 95% confidence interval (CI) 1.24–3.60, P=0.006) and EFS (HR= 1.71, 95% CI 1.07–2.75, P=0.025). The logistic regression model showed that MECOMpos was an independent prognostic factor regardless of minimal residual disease status post first induction therapy in the intermediate-risk group (odds ratio 2.89; 95% CI 1.19–6.57, P=0.018). Conclusion: The aberrant MECOM geneexpression is an adverse prognostic factor, especially in patients without previously known cytogenetic risk factors. Our results suggest the potential benefit from pre treatment screening for MECOM gene over expression in newly diagnosed AML patients for better risk stratification and treatment adjustment.

Speaker Biography

Mariam Elsherif is a consultant of paediatric oncology at the Children’s Cancer Hospital “CCHE, 57357” . Following her graduation from the Faculty of medicine, Ain Shams University in 2009, she started her residency at the department of paediatrics Ain Shams University” where she got her Master Degree in general paediatric in 2014 and subsequently completed my fellowship in Paediatric Hematology/Oncology CCHE and Dana Farber/Boston Children’s Hospital USA, in conjunction with earning my Doctorate degree in Paediatric Oncology from the National Cancer Institute, Cairo University.

Listen to this article

M Kussmann

Title- Translational clinical trials in nutrition

Speaker Abstract

Clinical trials in nutrition should explore, test, and validate nutritional solutions to maintain and improve human health. These solutions can come in the form of (micro-)nutrients, bioactives, (functional) ingredients, diets, or supplements. They can address digestive, metabolic, endocrine, immune, cardiovascular, muscle/bone and cognitive health. To render these trials more comparable and translational, traditional, and often non-standardized study designs must be complemented by clinical studies featuring the following characteristics:classical RCTs with group-average comparisons must be complemented by longitudinal, or (nested) n-of-1 studies, in which every subject is its own case and control; enrolled subjects should be clinically and molecularly phenotyped; administered diets, especially when applied under specific terms, should be clearly defined and described; intervention studies should apply safe, well-defined nutritional inputs or challenges and probe the elasticity of the human metabolic system in addition to sampling at homeostasis. Interventions can be betterinformed and designed upfront by bioinformatics and artificialintelligence:considering molecular mechanisms of e.g.metabolic, digestive,or immune health, the biological effects of bioactive ingredients (micronutrients, phytonutrients, pre-/probiotics, bioactive peptides) can be either computationally retrieved from existing literature4, or –to some extent– predicted in silico, thereby limiting the number of compounds or ingredients to be tested5. The best sources for those targeted functional nutritional compounds can be identified by computational mining of the genomes, metabolomes, and proteomes/peptidomes of e.g. plants and foods, thereby fostering both healthy and sustainable diets.

Speaker Biography

Dr. Martin Kussmann was trained as a biochemist and has accomplished a thirty years’ dual corporate/academic career with experience in nutrition, pharma, and biotechnology. He held professorships at EPF Lausanne, Switzerland; Aarhus University, Denmark; and Auckland University, New Zealand, where he was also Scientific Director of the National Science Program on Food Innovation. Kussmann spent thirteen years at Nestlé Research as Department Head and Primary Investigator. He has co-created and managed four research units and scientifically led two institutions. His research focuses on translational human studies in nutrition and health, multi-omics biomarker development, and artificial intelligence-enabled discovery and validation of natural bioactives. Kussmann is an internationally requested multi-lingual author, editor, and lecturer credited with ~150 publications, >30 media/press communications, and numerous presentations.

Listen to this article

 
 13:10-13:40 Intermission & Lunch Break

Abeer Dyoub

Title- Monitoring the ethical behavior of conversational agents in healthcare domains

Speaker Abstract

Conversational Agents (CA) are artificial intelligent software which can simulate a conversation with a user in natural language via auditory or textual methods. They are some of the industry’s newest tools designed to simplify the interaction between humans and computers. From a technological point of view, a CA only represents the natural evolution of question answering system leveraging Natural Language Processing and Understanding. In 2020, tele-health experienced an unprecedented uptake around the globe, with the COVID 19 pandemic acting as a catalyst. The COVID-19 pandemic accelerated the introduction of virtual healthcare delivery in many countries, it also prompted the rapid development of many other diverse technology-enabled systems and processes for delivering virtual healthcare to patients. One new technology development is the widespread uptake of conversational agents in people’s lives, and these now also have many health applications. Despite the potential benefits of the technology, CA raise many ethical concerns. In this Talk , I discuss ethical concerns of CA in healthcare domains in general and then present a proposal for monitoring the ethical behavior.

Speaker Biography

Abeer Dyoub is assistant professor at the Department of Engineering, Computer Science and Mathematics (DISIM), University of La'Aquila. Her research interest focuses on Artificial Intelligence, with special focus on Computational Logic including Intelligent Agents and Multi Agent Systems, Knowledge Representation and Reasoning, Interpretable Machine Learning, and Machine Ethics. She is a fellow of ACM, GRIN, AIxIA, and GULP. She holds a bachelor's degree in electronic engineering from Tishreen University, Syria 2000, a master's degree in computer science 2004 from JMI university, India, and a PhD in ICT from the University of L'Aquila, Italy, 2019.

Listen to this article

Nicoletta Fossati

Title- Automatic detection of potentially ineffective verbal communication for training through simulation

Speaker Abstract

Objectives: Artificial Intelligence models can extract human-factor relatedinformation from audio recordings. We present an automatic workflow detecting dialogue segments with potentially ineffective communicationbetween team membersduring neonatal simulation sessions. Materials and Methods: 10 cases from historical audio recordings of neonatalsimulation training sessions at Centro NINA, Maternal-Neonatal Department,AziendaOspedaliero-UniversitariaPisana (Pisa, Italy) were selected. The workflow analysed syllabic-scale (100-200 ms)spoken dialogue energy and intonation, using cluster analysis based on the K-means algorithm1.Tone units were detected, their audio segmentsextracted and, through cluster analysis of energy and pitch, labelled as either potentially ineffective or viable verbal communication. The audio of potentially ineffective unitswas transcribed through an automatic speech recogniser, and keywords extracted to produce a word cloud.Performance was measured against a gold standard containing annotations of 79 minutes of audio recordings from neonatal simulations, in Italian, under different noise conditions (from 4.63 to 14.17 SNR), compiled by two researchers with complementary expertise in the field. Results: Our workflow achieved a detection accuracy of 64% against a commercial automatic speech recogniser sentence accuracy of 9.37%. Detected keyword viability - the percentage of gold-standard words contained in the word cloud - was 59%.Potentially ineffective communication keywords includedrepeated items in the first person plural, and expressions of uncertainty, which may point toissues around leadership, self-confidence, and/or instruction clarity. There was no reference to time- or equipment/setting issues. Conclusion: Our workflow successfully identifiedeffective/ineffective communication during neonatal simulation sessions. It can be applied to other languages than Italian and can help trainersrefine feedback and measure learning improvement.

Speaker Biography

Dr. NicolettaFossatiwith a medical degree and a PhD, both from Pisa University and S. Anna School of Advanced Studies, complemented by a specialty degree in Anaesthesia and Resuscitation, She has held a consultant level job in Italy for 10 years before moving to London in 2004 to take on a Consultant Anaesthetist post at St George’s Hospital. In addition to anaesthesia, she has a long-standing interest in medical education. An Honorary Reader in Clinical Education and Anaesthesia at St George’s, University of London, she holds a Master’s degree in Higher and Professional Education (Institute of Education/UCL). In July 2022 she was awarded the Senior Fellowship of Advance HE/Higher Education Academy (SFHEA).

Listen to this article

Beshoy Effat Elkomos

Title- Surgical options for mid-transverse colon cancer; A systematic review and meta-analysis

Speaker Abstract

Background and Aim: The incidence of cancer colon below the age of 50 has increased dramatically. in addition, the database lacks a review to analyze the outcomes of surgeries for mid-transverse colon cancer with several recent controversial studies. Our aim was to compare the outcomes of extended hemicolectomy versus transverse colectomy for mid-transverse colon cancer. Method: PubMed, Scopes, Web of Science and Cochrane library were searched for eligible studies from inception to 1 May 2022 and a systematic review and meta-analysis were done to detect Results: according to eligibility criteria 8 studies (2237 patients) were included in our study. The pooled results of the included studies showed no difference in the 5-year OS, 3-year DFS and 5-year DFS between the two types of surgery (5-year OS, RR = 1.15, 95% CI = 0.94-1.39, P = 0.17), (3-year OS, RR = 0.96, 95% CI = 0.88-1.06, P = 0.42) and (5-year DFS, RR = 1.21, 95% CI = 0.91-1.62, P = 0.20). In addition to that, the recurrence rate and the incidence of complications were similar in the two groups (Recurrence rate, RR = 1.08, 95% CI = 0.62-1.89, P = 0.79) and (Complications, RR = 1.07, 95% CI = 0.74-1.54, P =0.72). however, the number of LN harvest and the time of the operation was more in case of extended hemicolectomy. Conclusion: Despite harvesting less LN, transverse colectomy has similar oncological outcomes to extended hemicolectomy for mid-transverse colon cancer. Moreover, no significant difference in the incidence of complications.

Speaker Biography

Beshoy Effat Elkomosis having 3 years experience as a surgical resident the at general surgery department, Ain sham university hospital. He is currently working at the general and emergency department, Northwick park hospital, LNWH NHS

Listen to this article

Brandon Lucke-Wold

Title- Diabetes mellitus management in the context of cranial tumors

Speaker Abstract

The study of the relationship between cancer and diabetes mellitus (DM) has been under investigation for many decades. Particularly in the field of neurology and neurosurgery, increasing emphasis has been put on the examination of comorbid DM in patients with cranial tumors. Namely, as the most common and invasive type of malignant adult brain tumor, glioblastoma (GBS) has been the focus of said research. Several mechanisms have been described in the attempt to elucidate the underlying association between DM and GBS, with the metabolic phenomenon known as the Warburg effect and its consequential downstream effects serving as the resounding culprits in recent literature. Since the effect seen in cancers like GBS exploits an upregulated form of aerobic glycolysis, the role of a sequela of DM, known as hyperglycemia, will be investigated. In particular, in the treatment of GBS, surgical resection and subsequent chemotherapy and/or radiotherapy are used in conjunction with corticosteroid therapy, the latter of which has been linked to hyperglycemia. Unsurprisingly, comorbid DM patients are significantly susceptible to this disposition. Further, this fact is reflected in recent literature that demonstrates the impact of hyperglycemia on cancer advancement and patient outcomes in several preclinical and clinical studies. Thus, this review will aim to underline the significance of diabetes and glycemic control via standard-of-care treatments such as metformin administration, as well as to describe emerging treatments such as the signaling modulation of insulin-like growth factor and the employment of the ketogenic diet.

Speaker Biography

Brandon Lucke-Wold was born and raised in Colorado Springs, CO. He graduatedmagna cum laude with a BS in Neuroscience and distinction in honors from BaylorUniversity. He completed his MD/PhD, Master’s in Clinical and TranslationalResearch, and the Global Health Track at West Virginia University School ofMedicine. His research focus was on traumatic brain injury, neurosurgicalsimulation, and stroke. At West Virginia University, he also served as a health coachfor the Diabetes Prevention and Management program in Morgantown and Charleston, WV, which significantly improved health outcomes for participants. In addition to his research and public health projects, he is a co-founder of the biotechnology company Wright-Wold Scientific, the pharmaceutical company CTE cure, and was a science advocate on Capitol Hill through the Washington Fellow’s program.He has also served as president of the WVU chapters for the American Association ofPharmaceutical Scientists, Neurosurgery Interest group, and Erlenmeyer Initiative Entrepreneur group. In addition, he has served as vice president for the graduate student neuroscience interest group, Nu Rho Psi Honor Society, and medical students for global health. He was an active member of the Gold Humanism Honor Society and Alpha Omega Alpha Honor Society. He is currently a member of the UF House Staff Council, Positive Culture Committee, Quality Improvement Committee, Board of Directors Alachua County Medical Society, and Accreditation Requirements Review Committee. He is married to Noelle Lucke-Wold and has two children. As a family, they enjoy running with their dogs, rock climbing, and traveling. In his spare time, Brandon frequently runs half marathons and 10ks together with is wife. Brandon also enjoys reading, playing piano, discussing philosophy, and playing chess. He is currently a Pgy5 neurosurgery resident at University of Florida with pursuing endovascular enfolded training and was awarded the Dempsey Cerebrovascular Research Fellowship.

Listen to this article

+1 (506) 909-0537